NCT00067301View on ClinicalTrials.gov

PUFA Augmentation in Treatment of Major Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Major Depression
Interventions
DRUG

Polyunsaturated Fatty Acids (PUFA)

DRUG

Citalopram

Trial Locations (1)

90048

Cedars-Sinai Medical Center Dept. of Psychiatry, Los Angeles

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00067301 - PUFA Augmentation in Treatment of Major Depression | Biotech Hunter | Biotech Hunter